Phenotype-driven cascade screening in a Syrian family with clinically consistent multiple endocrine neoplasia type 2A. [PDF]
Hraib M +3 more
europepmc +1 more source
Magnitude of Survival Benefit Associated With Tyrosine Kinase Inhibitors in Advanced Thyroid Carcinoma: A Systematic Review and Meta-Analysis Incorporating Updated Long-Term Evidence From SELECT (Lenvatinib) and COSMIC-311 (Cabozantinib) Trials. [PDF]
Roy P +3 more
europepmc +1 more source
Pentraxin-3 in thyroid nodules: a systemic marker of pathology and a local mediator of inflammation and carcinoma. [PDF]
Cieri M +10 more
europepmc +1 more source
Application Value of Multi-Gene Testing in the Evaluation of Benign and Malignant Thyroid Nodules. [PDF]
Zhang M +8 more
europepmc +1 more source
Diagnostic concordance of remote WSI-based thyroid cytology compared to conventional cytological diagnosis: a pilot study. [PDF]
Şahi̇n AF +4 more
europepmc +1 more source
How to manage radioiodine-refractory thyroid cancer in the era of precision medicine. [PDF]
Karapanou O +3 more
europepmc +1 more source
DICER1 alterations in thyroid lesions: a systematic review and meta-analysis with clinicopathologic implications. [PDF]
Straccia P +5 more
europepmc +1 more source
An unusual case of a hypervascular solid pancreatic lesion: all that glitters is not gold. [PDF]
Tortorici F +4 more
europepmc +1 more source
BRAF and MEK inhibitors in the treatment of aggressive thyroid carcinomas [PDF]
Salerno, Paolo
core

